Effects of L- and D-REKR amino acid-containing peptides on HIV and SIV envelope glycoprotein precursor maturation and HIV and SIV replication
- PMID: 12071862
- PMCID: PMC1222836
- DOI: 10.1042/BJ20020052
Effects of L- and D-REKR amino acid-containing peptides on HIV and SIV envelope glycoprotein precursor maturation and HIV and SIV replication
Abstract
The aim of the present study was to evaluate the capacity of synthetic l- and d-peptides encompassing the HIV-1(BRU) gp160 REKR cleavage site to interfere with HIV and simian immuno-deficiency virus (SIV) replication and maturation of the envelope glycoprotein (Env) precursors. To facilitate their penetration into cells, a decanoyl (dec) group was added at the N-terminus. The sequences synthesized included dec5d or dec5l (decREKRV), dec9d or dec9l (decRVVQREKRV) and dec14d or dec14l (TKAKRRVVQREKRV). The peptide dec14d was also prepared with a chloromethane (cmk) group as C-terminus. Because l-peptides exhibit significant cytotoxicity starting at 35 microM, further characterization was conducted mostly with d-peptides, which exhibited no cytotoxicity at concentrations higher than 70 microM. The data show that only dec14d and dec14dcmk could inhibit HIV-1(BRU), HIV-2(ROD) and SIV(mac251) replication and their syncytium-inducing capacities. Whereas peptides dec5d and dec9d were inactive, dec14dcmk was at least twice as active as peptide dec14d. At the molecular level, our data show a direct correlation between anti-viral activity and the ability of the peptides to interfere with maturation of the Env precursors. Furthermore, we show that when tested in vitro the dec14d peptide inhibited PC7 with an inhibition constant K(i)=4.6 microM, whereas the peptide dec14l preferentially inhibited furin with a K(i)=28 microM. The fact that PC7 and furin are the major prohormone convertases reported to be expressed in T4 lymphocytes, the principal cell targets of HIV, suggests that they are involved in the maturation of HIV and SIV Env precursors.
Similar articles
-
An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step.Virology. 2000 Jul 20;273(1):169-77. doi: 10.1006/viro.2000.0368. Virology. 2000. PMID: 10891419
-
Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV.J Med Chem. 2005 Apr 21;48(8):3036-44. doi: 10.1021/jm049026h. J Med Chem. 2005. PMID: 15828842
-
An anti-HIV peptide construct derived from the cleavage region of the Env precursor acts on Env fusogenicity through the presence of a functional cleavage sequence.Virology. 1998 Aug 1;247(2):137-43. doi: 10.1006/viro.1998.9239. Virology. 1998. PMID: 9705906
-
Maturation of HIV envelope glycoprotein precursors by cellular endoproteases.Biochim Biophys Acta. 2000 Nov 10;1469(3):121-32. doi: 10.1016/s0304-4157(00)00014-9. Biochim Biophys Acta. 2000. PMID: 11063880 Review.
-
How entry inhibitors synergize to fight HIV.J Biol Chem. 2017 Oct 6;292(40):16511-16512. doi: 10.1074/jbc.H117.791731. J Biol Chem. 2017. PMID: 28986430 Free PMC article. Review.
Cited by
-
Predicting proteolytic sites in extracellular proteins: only halfway there.Bioinformatics. 2008 Apr 15;24(8):1049-55. doi: 10.1093/bioinformatics/btn084. Epub 2008 Mar 4. Bioinformatics. 2008. PMID: 18321887 Free PMC article.
-
HIV envelope: challenges and opportunities for development of entry inhibitors.Trends Microbiol. 2011 Apr;19(4):191-7. doi: 10.1016/j.tim.2011.02.001. Epub 2011 Mar 4. Trends Microbiol. 2011. PMID: 21377881 Free PMC article. Review.
-
Inhibitors of proprotein convertases.J Mol Med (Berl). 2005 Nov;83(11):844-55. doi: 10.1007/s00109-005-0710-0. Epub 2005 Oct 8. J Mol Med (Berl). 2005. PMID: 16215768 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous